Teva's generic Advair may sit 'til 2018 - Medical Marketing and Media

09-10-2013 Medical Marketing and MediaComments (0)

GenericsTeva Pharmaceutical Industries

September FDA draft guidance looked like it could make it easier for generics of GlaxoSmithKline's asthma/COPD medication Advair to hit the market. The issue at the time was that the guidance indicated generics rivals could bypass human trials in their ...

Read more on Medical Marketing and Media

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top